abstract |
The present application relates to a series ofncompounds, and pharmaceutical formulations thereof, ofnthe formulan nwhich provide a method of inhibiting hyperlipidemia,nespecially hypercholesterolemia, and the pathologicalnsequelae thereof, in mammals, including humans. |